Olaris

Olaris, Inc | Biomarkers of Response (BoRs) | Framingham, Massachusetts

Framingham, United States · Founded 2014 · $15.0M raised

Employees
11–50
Founded
2014
Business Model
B2B
Total Funding
$15.0M
Last Round
$15.0M Corporate RoundApr 2025
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 3 investors for this company. The full record is or through the API.

About

Olaris brings together biology, metabolomics, and machine learning to build diagnostics designed for real clinical decisions, in real clinical settings. The company states that it is accountable to science and that it will always strive to do better. Its diagnostics aim to be relevant, usable and impactful in real-world care.

Summary

Olaris is a Biotech company based in Framingham, United States, founded in 2014. It has raised $15.0M in total across 4 rounds, most recently a $15.0M Corporate Round in Apr 2025. Investors include Labcorp, Innospark Ventures and Alumni Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Corporate RoundCorporate RoundApr 2025
$15.0M

Sign up to see all 4 events

Funding: Seed through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Olaris on Indexed.vc
<a href="https://indexed.vc/companies/olaris"><img src="https://indexed.vc/api/badge/company/olaris" alt="Olaris on Indexed.vc" width="260" height="76" /></a>